Cooper Q2 2020 Earnings Report
Key Takeaways
CooperCompanies reported a 20% decrease in revenue to $524.9 million, with GAAP diluted earnings per share down 91% to $0.23 and non-GAAP diluted earnings per share down 48% to $1.51 compared to the same quarter last year. The company experienced a decrease in revenue for both CooperVision and CooperSurgical segments.
Revenue decreased 20% year-over-year to $524.9 million.
CooperVision (CVI) revenue was down 17% to $402.2 million.
CooperSurgical (CSI) revenue was down 28% to $122.7 million.
GAAP diluted earnings per share decreased to $0.23, a 91% decrease year-over-year.
Cooper
Cooper
Cooper Revenue by Segment
Cooper Revenue by Geographic Location
Forward Guidance
Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is no longer providing fiscal year 2020 guidance.
Revenue & Expenses
Visualization of income flow from segment revenue to net income